Brief: SHL Telemedicine Files Pre-Submission With FDA For Over The Counter Clearance Of Smartheart Full 12 Lead ECG
Jan 12 (Reuters) - SHL Telemedicine Ltd SHLTN.S :
* SHL TELEMEDICINE FILES PRE-SUBMISSION WITH FDA FOR OVER
THE
COUNTER CLEARANCE OF SHL’S SMARTHEART™ FULL 12 LEAD ECG
* FILES PRE-SUBMISSION WITH FDA FOR OVER COUNTER CLEARANCE
OF
SHL'S SMARTHEART™ FULL 12 LEAD ECG
* FDA'S PRE-SUBMISSION PROGRAM (PRE-SUB) ALLOWS MEDICAL
DEVICE
MANUFACTURERS TO DISCUSS SPECIFIC ASPECTS OF REGULATORY PROCESS
AND REQUIREMENTS WITH FDA.
Source text for Eikon: ID:nTEN2ekdaa
Further company coverage: SHLTN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SHL Telemedicine
See all newsBrief: SHL Says Write-Off Of Goodwill Allocated To German Operations Of About $13 Million
Brief: SHL Telemedicine Acquisition Of Remaining 30% Stake Of Mediton Group
Brief: SHL Telemedicine To Purchase Remaining 30% Stake In Mediton Group For NIS 31.1 Million
Brief: Docgo Expanded Partnership With SHL Telemedicine
Brief: Y.D More Investments Reports 12.9% Passive Stake In SHL Telemedicine As Of Sept 30